HITAC Recommendations on ONC Adopted Standards

Retrieved By Health eConsultation 0 17 Article rating: No rating

The Health Information Technology Advisory Committee (HITAC) recently submitted their final report and recommendations related to ONC adopted standards and implementation specifications referenced in federal regulations. The report and recommendations are based on the work of the HITAC’s 2022 Adopted Standards Task Force and are responsive to a 21st Century Cures Act (Cures Act) (42 U.S. Code § 300jj–13) provision that requires the national coordinator to convene stakeholders to review the existing set of adopted standards and implementation specifications and make recommendations with respect to whether to maintain the use of such standards and implementation specifications;

The post HITAC Recommendations on ONC Adopted Standards appeared first on Health IT Buzz.

Actionable ways to meet the 2015 Edition Cures Update requirements

Retrieved By Health eConsultation 0 21 Article rating: No rating

The 2015 Edition Cures Update made several changes to the ONC Health IT Certification Program (Certification Program), including new functionalities; new, removed, and revised criteria; and new requirements establishing the Conditions and Maintenance of Certification. This means that most health IT developers of certified health IT (certified health IT developers) will be required to update their certified Health IT Modules by December 31, 2022. As we approach this deadline, it is important to remember that meeting the Certification Program requirements and avoiding non-conformities is up to each certified health IT developer.

The post Actionable ways to meet the 2015 Edition Cures Update requirements appeared first on Health IT Buzz.

OSTP, in Partnership with ONC, Seeks Input on Optimizing Data Capture for Clinical Trials

Retrieved By Health eConsultation 0 14 Article rating: No rating

This blog post is co-authored with Jennifer Roberts, Assistant Director for Health Technologies, White House Office of Science and Technology Policy, and Grail Sipes, Assistant Director for Biomedical Regulatory Policy, White House Office of Science and Technology Policy.
The COVID-19 pandemic demonstrated the need for a coordinated clinical trials enterprise, one that can swiftly characterize emerging viral threats and evaluate the effectiveness of vaccines, therapeutics, and other countermeasures across a diversity of trial participants.

The post OSTP, in Partnership with ONC, Seeks Input on Optimizing Data Capture for Clinical Trials appeared first on Health IT Buzz.

First2526272830323334Last